Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1867006870864003072 |
|---|---|
| author | Mercè Grau‐Pérez Pedro Mercader‐García Ana María Giménez‐Arnau Tatiana Sanz‐Sánchez Violeta Zaragoza Ninet Susana Córdoba Guijarro Francisco Javier Miquel Miquel Juan Francisco Silvestre Salvador Ricardo González‐Pérez Inmaculada Ruíz González Esther Serra Baldrich José Manuel Carrascosa Francisco Javier Ortiz de Frutos Mercedes Rodríguez Serna María Elena Gatica Ortega Carmen Paredes Suárez Francisco José Navarro Triviño Pablo Chicharro Marta Andreu Araceli Sánchez Gilo José Juan Pereyra Rodríguez María Antonia Pastor Nieto Gemma Melé‐Ninot Paloma Sánchez‐Pedreño Guillén Enrique Gómez de la Fuente Marta Elosua‐González Mónica Munera‐Campos Fátima Tous Romero Miguel Ángel Descalzo Leopoldo Borrego |
| author_facet | Mercè Grau‐Pérez Pedro Mercader‐García Ana María Giménez‐Arnau Tatiana Sanz‐Sánchez Violeta Zaragoza Ninet Susana Córdoba Guijarro Francisco Javier Miquel Miquel Juan Francisco Silvestre Salvador Ricardo González‐Pérez Inmaculada Ruíz González Esther Serra Baldrich José Manuel Carrascosa Francisco Javier Ortiz de Frutos Mercedes Rodríguez Serna María Elena Gatica Ortega Carmen Paredes Suárez Francisco José Navarro Triviño Pablo Chicharro Marta Andreu Araceli Sánchez Gilo José Juan Pereyra Rodríguez María Antonia Pastor Nieto Gemma Melé‐Ninot Paloma Sánchez‐Pedreño Guillén Enrique Gómez de la Fuente Marta Elosua‐González Mónica Munera‐Campos Fátima Tous Romero Miguel Ángel Descalzo Leopoldo Borrego Mercè Grau‐Pérez Pedro Mercader‐García Ana María Giménez‐Arnau Tatiana Sanz‐Sánchez Violeta Zaragoza Ninet Susana Córdoba Guijarro Francisco Javier Miquel Miquel Juan Francisco Silvestre Salvador Ricardo González‐Pérez Inmaculada Ruíz González Esther Serra Baldrich José Manuel Carrascosa Francisco Javier Ortiz de Frutos Mercedes Rodríguez Serna María Elena Gatica Ortega Carmen Paredes Suárez Francisco José Navarro Triviño Pablo Chicharro Marta Andreu Araceli Sánchez Gilo José Juan Pereyra Rodríguez María Antonia Pastor Nieto Gemma Melé‐Ninot Paloma Sánchez‐Pedreño Guillén Enrique Gómez de la Fuente Marta Elosua‐González Mónica Munera‐Campos Fátima Tous Romero Miguel Ángel Descalzo Leopoldo Borrego |
| collection | Wiley Open Access |
| contents | Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024 Mercè Grau‐Pérez Pedro Mercader‐García Ana María Giménez‐Arnau Tatiana Sanz‐Sánchez Violeta Zaragoza Ninet Susana Córdoba Guijarro Francisco Javier Miquel Miquel Juan Francisco Silvestre Salvador Ricardo González‐Pérez Inmaculada Ruíz González Esther Serra Baldrich José Manuel Carrascosa Francisco Javier Ortiz de Frutos Mercedes Rodríguez Serna María Elena Gatica Ortega Carmen Paredes Suárez Francisco José Navarro Triviño Pablo Chicharro Marta Andreu Araceli Sánchez Gilo José Juan Pereyra Rodríguez María Antonia Pastor Nieto Gemma Melé‐Ninot Paloma Sánchez‐Pedreño Guillén Enrique Gómez de la Fuente Marta Elosua‐González Mónica Munera‐Campos Fátima Tous Romero Miguel Ángel Descalzo Leopoldo Borrego Contact Dermatitis ABSTRACT Background The REIDAC (Spanish Registry for Research in Contact Dermatitis) conducts nationwide epidemiological surveillance of contact dermatitis in Spain. Anogenital involvement within REIDAC has not been previously studied. Objectives To describe the most common diagnoses and update relevant allergens in patients with anogenital lesions referred for patch testing. Methods We analysed patients who underwent patch testing within REIDAC from 2019 to 2024. Patients were classified into three groups: (G1) exclusively anogenital lesions, (G2) no anogenital involvement and (G3) both anogenital and non‐anogenital lesions. Sensitisation and relevance were assessed. Results Among 18 291 patients, 116 (0.6%) had exclusively anogenital lesions, 17 576 (96.1%) had no anogenital involvement and 599 (3.3%) had both. G1 patients were more likely to have at least one positive reaction (91.4%), a current relevant reaction (53.4%, diagnosed with allergic contact dermatitis, ACD) and to be polysensitised compared to other groups ( p < 0.001). 14.5% of anogenital ACD identified cases were not identified by the Spanish baseline series. Fragrances, preservatives, topical anaesthetics and steroids were the leading relevant allergens. Benzisothiazolinone, sodium metabisulfite and propolis emerged as new sensitisers. Conclusion ACD was highly prevalent among patients with anogenital lesions referred for patch testing. The threshold for patch testing in these patients may need reconsideration. 10.1111/cod.70048 http://creativecommons.org/licenses/by-nc/4.0/ |
| doi_str_mv | 10.1111/cod.70048 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_cod_70048 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc/4.0/ |
| publishDate | 2025 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024 Mercè Grau‐Pérez Pedro Mercader‐García Ana María Giménez‐Arnau Tatiana Sanz‐Sánchez Violeta Zaragoza Ninet Susana Córdoba Guijarro Francisco Javier Miquel Miquel Juan Francisco Silvestre Salvador Ricardo González‐Pérez Inmaculada Ruíz González Esther Serra Baldrich José Manuel Carrascosa Francisco Javier Ortiz de Frutos Mercedes Rodríguez Serna María Elena Gatica Ortega Carmen Paredes Suárez Francisco José Navarro Triviño Pablo Chicharro Marta Andreu Araceli Sánchez Gilo José Juan Pereyra Rodríguez María Antonia Pastor Nieto Gemma Melé‐Ninot Paloma Sánchez‐Pedreño Guillén Enrique Gómez de la Fuente Marta Elosua‐González Mónica Munera‐Campos Fátima Tous Romero Miguel Ángel Descalzo Leopoldo Borrego Contact Dermatitis Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024 Mercè Grau‐Pérez Pedro Mercader‐García Ana María Giménez‐Arnau Tatiana Sanz‐Sánchez Violeta Zaragoza Ninet Susana Córdoba Guijarro Francisco Javier Miquel Miquel Juan Francisco Silvestre Salvador Ricardo González‐Pérez Inmaculada Ruíz González Esther Serra Baldrich José Manuel Carrascosa Francisco Javier Ortiz de Frutos Mercedes Rodríguez Serna María Elena Gatica Ortega Carmen Paredes Suárez Francisco José Navarro Triviño Pablo Chicharro Marta Andreu Araceli Sánchez Gilo José Juan Pereyra Rodríguez María Antonia Pastor Nieto Gemma Melé‐Ninot Paloma Sánchez‐Pedreño Guillén Enrique Gómez de la Fuente Marta Elosua‐González Mónica Munera‐Campos Fátima Tous Romero Miguel Ángel Descalzo Leopoldo Borrego Contact Dermatitis ABSTRACT Background The REIDAC (Spanish Registry for Research in Contact Dermatitis) conducts nationwide epidemiological surveillance of contact dermatitis in Spain. Anogenital involvement within REIDAC has not been previously studied. Objectives To describe the most common diagnoses and update relevant allergens in patients with anogenital lesions referred for patch testing. Methods We analysed patients who underwent patch testing within REIDAC from 2019 to 2024. Patients were classified into three groups: (G1) exclusively anogenital lesions, (G2) no anogenital involvement and (G3) both anogenital and non‐anogenital lesions. Sensitisation and relevance were assessed. Results Among 18 291 patients, 116 (0.6%) had exclusively anogenital lesions, 17 576 (96.1%) had no anogenital involvement and 599 (3.3%) had both. G1 patients were more likely to have at least one positive reaction (91.4%), a current relevant reaction (53.4%, diagnosed with allergic contact dermatitis, ACD) and to be polysensitised compared to other groups ( p < 0.001). 14.5% of anogenital ACD identified cases were not identified by the Spanish baseline series. Fragrances, preservatives, topical anaesthetics and steroids were the leading relevant allergens. Benzisothiazolinone, sodium metabisulfite and propolis emerged as new sensitisers. Conclusion ACD was highly prevalent among patients with anogenital lesions referred for patch testing. The threshold for patch testing in these patients may need reconsideration. 10.1111/cod.70048 http://creativecommons.org/licenses/by-nc/4.0/ |
| title | Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024 |
| topic | Contact Dermatitis |
| url | https://onlinelibrary.wiley.com/doi/10.1111/cod.70048 |